![Does the Institute for Clinical and Economic Review Revise Its Findings in Response to Industry Comments? - ScienceDirect Does the Institute for Clinical and Economic Review Revise Its Findings in Response to Industry Comments? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1098301519323459-gr1.jpg)
Does the Institute for Clinical and Economic Review Revise Its Findings in Response to Industry Comments? - ScienceDirect
![Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates](https://www.ohe.org/sites/default/files/styles/publication-full/public/publication-covers/Value%2C%20Access%2C%20and%20Incentives%20for%20Innovation%20-%20Policy%20Perspectives%20on%20Alternative%20Models%20for%20Pharmaceutical%20Rebates.jpg?itok=fgez1O_A)
Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates
![Digital Health Outcomes launched interactive health economic modeling platform together with the Institute for Clinical and Economic review (ICER). | Digital Health Outcomes Digital Health Outcomes launched interactive health economic modeling platform together with the Institute for Clinical and Economic review (ICER). | Digital Health Outcomes](https://digitalho.com/wp-content/uploads/2021/02/screenshot-2021-02-03-at-15.02.15.png)
Digital Health Outcomes launched interactive health economic modeling platform together with the Institute for Clinical and Economic review (ICER). | Digital Health Outcomes
![White Paper: The Growing Influence of the Institute of Clinical and Economic Review on Payer Decisions in the US - Evidera White Paper: The Growing Influence of the Institute of Clinical and Economic Review on Payer Decisions in the US - Evidera](https://www.evidera.com/wp-content/uploads/2019/10/shutterstock-1023953008-paper-1600x600-1.jpg)
White Paper: The Growing Influence of the Institute of Clinical and Economic Review on Payer Decisions in the US - Evidera
![Key Questions for Legislators on the Institute for Clinical and Economic Review (ICER) | Health Care Latest News Key Questions for Legislators on the Institute for Clinical and Economic Review (ICER) | Health Care Latest News](https://pioneerinstitute.org/wp-content/uploads/27854267179_5d8dc9c17f_o-1.jpg)
Key Questions for Legislators on the Institute for Clinical and Economic Review (ICER) | Health Care Latest News
![Milliman Study on the Utility of ICER Reports for Private Payer Drug Coverage Decision-Making | PhRMA Milliman Study on the Utility of ICER Reports for Private Payer Drug Coverage Decision-Making | PhRMA](https://phrma.org/-/media/Project/PhRMA/PhRMA-Org/PhRMA-Org/Teaser-Image/Advocacy/md_1000x635_ICER-new2.jpg)
Milliman Study on the Utility of ICER Reports for Private Payer Drug Coverage Decision-Making | PhRMA
![The Institute for Clinical and Economic Review (ICER) frequently use RWE in their scoping process | SVM Pharma The Institute for Clinical and Economic Review (ICER) frequently use RWE in their scoping process | SVM Pharma](https://svmpharma.com/wp-content/uploads/2022/02/002-Jan-2021-CW.png)
The Institute for Clinical and Economic Review (ICER) frequently use RWE in their scoping process | SVM Pharma
![ICER's Final Report on Peanut Allergy Treatments: Clinical Evidence Does Not Yet Demonstrate That Long-Term Benefits of Desensitization Outweigh Short-Term Risks | SnackSafely.com ICER's Final Report on Peanut Allergy Treatments: Clinical Evidence Does Not Yet Demonstrate That Long-Term Benefits of Desensitization Outweigh Short-Term Risks | SnackSafely.com](https://media.snacksafely.com/wp-content/uploads/2019/07/ICER-Final-Report.jpg)
ICER's Final Report on Peanut Allergy Treatments: Clinical Evidence Does Not Yet Demonstrate That Long-Term Benefits of Desensitization Outweigh Short-Term Risks | SnackSafely.com
![Steven Pearson, Founder and President of the Institute for Clinical and Economic Review (ICER), poses for a portrait for Reuters at ICER's offices in Boston, Massachusetts, U.S., January 2, 2020. Picture taken Steven Pearson, Founder and President of the Institute for Clinical and Economic Review (ICER), poses for a portrait for Reuters at ICER's offices in Boston, Massachusetts, U.S., January 2, 2020. Picture taken](https://l450v.alamy.com/450v/2cggaft/steven-pearson-founder-and-president-of-the-institute-for-clinical-and-economic-review-icer-poses-for-a-portrait-for-reuters-at-icers-offices-in-boston-massachusetts-us-january-2-2020-picture-taken-january-2-2020-reutersbrian-snyder-to-match-special-report-usa-drugpricinglobbying-2cggaft.jpg)
Steven Pearson, Founder and President of the Institute for Clinical and Economic Review (ICER), poses for a portrait for Reuters at ICER's offices in Boston, Massachusetts, U.S., January 2, 2020. Picture taken
![Final Report by Institute for Clinical and Economic Review Raises Concerns in the Rheumatology Community Final Report by Institute for Clinical and Economic Review Raises Concerns in the Rheumatology Community](http://d2geqc87xuuo99.cloudfront.net/web/RPM/2017/June/TableRPMJune2017.png)